<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Progress note - [REDACTED]</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body>
<h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Allergies</a></li><li><a href="#id2">Reason For Referral</a></li><li><a href="#id3">REASON FOR VISIT</a></li><li><a href="#id4">Medications</a></li><li><a href="#id5">Problems</a></li><li><a href="#id6">Vital Signs</a></li><li><a href="#id7">Procedures</a></li><li><a href="#id8">Encounters</a></li><li><a href="#id9">Assessments</a></li><li><a href="#id10">Plan Of Treatment</a></li><li><a href="#id11">Progress Notes</a></li><li><a href="#id12">History and Physical Notes</a></li><li><a href="#id13">Consultation Request Notes</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Allergies</a></h3><div><table width="100%" border="1"><thead><tr><th>Allergen (clinical drug ingredient)</th><th>Drug/Non Drug Allergy documented on EMR</th><th>Reaction</th><th>Allergy Type</th><th>Onset Date</th><th>Status</th></tr></thead><tbody><tr><td ID="allergy1">acetaminophen</td><td>Tylenol</td><td ID="reaction1">Unknown</td><td>Drug Allergy</td><td/><td>Active</td></tr><tr><td ID="allergy2">sulfacetamide</td><td>Sulfacetamide</td><td ID="reaction2">Unknown</td><td>Drug Allergy</td><td/><td>Active</td></tr></tbody></table></div><h3><a name="id2" href="#toc">Reason For Referral</a></h3><div><table width="100%" border="1"><tbody><tr><th>Reason</th><td>2 x per week for 6 wks | Eval and treat</td></tr><tr><th>Diagnosis 1</th><td>Sciatica, left side (M54.32)</td></tr><tr><th>Diagnosis 2</th><td>Primary osteoarthritis of both hips (M16.0)</td></tr><tr><th>Referral Organization</th><td>ClareMedica of [REDACTED]</td></tr><tr><th>Referring Provider First Name</th><td>[REDACTED]</td></tr><tr><th>Referring Provider Last Name</th><td>[REDACTED]</td></tr><tr><th>Referring Provider Speciality</th><td>Internal Medicine</td></tr><tr><th>Referred Provider</th><td>Select Physical Therapy</td></tr><tr><th>Referred Provider Specialty</th><td>Physical Therapist</td></tr><tr><th>General Notes</th><td>[REDACTED] [REDACTED] 01:57:57 PM &gt;Faxed to provider. They will contact pt to schedule</td></tr><tr><th>Referral Priority</th><td>Routine</td></tr></tbody></table><table width="100%" border="1"><tbody><tr><th>Reason</th><td>OSA; eval via polysomnogram</td></tr><tr><th>Diagnosis 1</th><td>Obstructive sleep apnea (adult) (pediatric) (G47.33)</td></tr><tr><th>Referral Organization</th><td>ClareMedica of [REDACTED]</td></tr><tr><th>Referring Provider First Name</th><td>[REDACTED]</td></tr><tr><th>Referring Provider Last Name</th><td>[REDACTED]</td></tr><tr><th>Referring Provider Speciality</th><td>Internal Medicine</td></tr><tr><th>Referred Provider</th><td>Blackstone Medical Services</td></tr><tr><th>Referred Provider Specialty</th><td>Sleep Medicine</td></tr><tr><th>Procedure 1</th><td>HST TYPE III PRTBLE MON MIN 4 CH (G0399)</td></tr><tr><th>General Notes</th><td>[REDACTED] [REDACTED] 01:51:48 PM &gt;Faxed to Careplus for auth</td></tr><tr><th>Referral Priority</th><td>Routine</td></tr></tbody></table></div><h3><a name="id3" href="#toc">REASON FOR VISIT</a></h3><div>follow up visit</div><h3><a name="id4" href="#toc">Medications</a></h3><div><table width="100%" border="1"><thead><tr><th>Medication</th><th>SIG (Take, Route, Frequency, Duration)</th><th>Notes</th><th>Start Date</th><th>End Date</th><th>Status</th></tr></thead><tbody><tr><td ID="medication1">Accu-Chek Guide w/Device</td><td ID="instruction1">as directed</td><td/><td>[REDACTED]</td><td/><td>Unknown</td></tr><tr><td ID="medication2">Accu-Chek Guide -</td><td ID="instruction2"><p>as directed In Vitro 2 times a day In Vitro twice for 90 days</p><p>As needed</p></td><td/><td>[REDACTED]</td><td/><td>Unknown</td></tr><tr><td ID="medication3">Ipratropium Bromide 3.0E-4</td><td ID="instruction3"> Nasal every 12 hours for 30</td><td/><td>[REDACTED]</td><td/><td>Not-Taking</td></tr><tr><td ID="medication4">predniSONE 5 MG</td><td ID="instruction4">4 tabs orally 2 times a day for 4 days, then 3 tabs orally 2 times a day for 1 day, then 2 tabs orally 2 times a day for 1 day, then 1 tab orally 2 times a day for 1 day, then 1 tab Orally Once a day</td><td/><td>[REDACTED]</td><td/><td>Active</td></tr><tr><td ID="medication5">Accu-Chek Softclix Lancets -</td><td ID="instruction5">as directed 2 times a day</td><td/><td/><td/><td>Unknown</td></tr><tr><td ID="medication6">glipiZIDE 5 MG</td><td ID="instruction6"><p>1 tablet orally before meals Orally 2 times a day</p><p>As needed</p></td><td/><td>[REDACTED]</td><td/><td>Not-Taking</td></tr><tr><td ID="medication7">Furosemide 20 MG</td><td ID="instruction7">TAKE 1 TABLET BY MOUTH EVERY DAY FOR 30 DAYS for 30</td><td/><td/><td/><td>Not-Taking</td></tr><tr><td ID="medication8">Fluocinonide 0.05 %</td><td ID="instruction8"><p>1 application Externally Twice a day</p><p>to affected area</p></td><td/><td/><td/><td>Not-Taking</td></tr><tr><td ID="medication9">Famotidine 40 MG</td><td ID="instruction9">1 tablet at bedtime Orally Once a day</td><td/><td>[REDACTED]</td><td/><td>Not-Taking</td></tr><tr><td ID="medication10">Pregabalin 100 MG</td><td ID="instruction10">1 capsule Orally 3 times a day for 30 days</td><td/><td>[REDACTED]</td><td>[REDACTED]</td><td>Active</td></tr><tr><td ID="medication11">Mounjaro 7.5 MG/0.5ML</td><td ID="instruction11"><p>7.5 mg Subcutaneous Once a Week for 28 days</p><p>Disp: 1 month supply</p></td><td/><td>[REDACTED]</td><td>[REDACTED]</td><td>Active</td></tr><tr><td ID="medication12">metFORMIN HCl ER 500 MG</td><td ID="instruction12">1 tablet with evening meal Orally twice a day for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication13">Losartan Potassium 25 MG</td><td ID="instruction13">1 tablet Oral Twice a Day for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication14">Simvastatin 10 MG</td><td ID="instruction14">1 tablet in the evening Oral Once a day for 90 days</td><td/><td>[REDACTED]</td><td/><td>Active</td></tr><tr><td ID="medication15">oxyBUTYnin Chloride ER 10 MG</td><td ID="instruction15">TAKE 1 TABLET BY MOUTH EVERY DAY Orally Once a day for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication16">Lactulose 10 GM/15ML</td><td ID="instruction16">TAKE 2 TABLESPOONS (30ML) BY MOUTH DAILY BEFORE BED AS NEEDED</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication17">dilTIAZem HCl 120 MG</td><td ID="instruction17">TAKE 1 TABLET BY MOUTH TWICE A DAY FOR 90 DAYS for 90</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication18">Clotrimazole-Betamethasone 1-0.05 %</td><td ID="instruction18"> External every 12 hours for 30</td><td/><td>[REDACTED]</td><td/><td>Active</td></tr><tr><td ID="medication19">Atenolol 50 MG</td><td ID="instruction19">1 tablet Oral Once a day for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication20">LORazepam 0.5 MG</td><td ID="instruction20">1 tablet at bedtime as needed Oral once a day for 30 days</td><td/><td>[REDACTED]</td><td/><td>Active</td></tr><tr><td ID="medication21">Celecoxib 100 MG</td><td ID="instruction21">1 CAPSULE WITH FOOD ORALLY 2 TIMES A DAY START AFTER COMPLETING PREDNISONE. 30 DAYS for 30</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication22">Pantoprazole Sodium 40 MG</td><td ID="instruction22">TAKE 1 TABLET BY MOUTH EVERY DAY FOR 30 DAYS for 30</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication23">Allopurinol 100 MG</td><td ID="instruction23">1 tablet Orally Once a day</td><td/><td>[REDACTED]</td><td/><td>Active</td></tr><tr><td ID="medication24">Proctosol HC 2.5 %</td><td ID="instruction24"><p>1 application Externally Twice a day</p><p>As needed to affected area</p></td><td/><td/><td/><td>Active</td></tr></tbody></table></div><h3><a name="id5" href="#toc">Problems</a></h3><div><table width="100%" border="1"><thead><tr><th>Problem Type</th><th>SNOMED Code</th><th>ICD Code</th><th>Onset Dates</th><th>Problem Status</th><th>W/U Status</th><th>Risk</th><th>Notes</th></tr></thead><tbody><tr><td>Problem</td><td>840580004</td><td ID="Problem1">Peripheral arterial disease (I73.9)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr></tbody></table></div><h3><a name="id6" href="#toc">Vital Signs</a></h3><div><table width="100%" border="1"><tbody><tr><th ID="vital1">Temperature</th><td>97 degrees Fahrenheit</td><td>[REDACTED]</td></tr><tr><th ID="vital2">Blood pressure systolic</th><td>125 mm Hg</td><td>[REDACTED]</td></tr><tr><th ID="vital3">Blood pressure diastolic</th><td>77 mm Hg</td><td>[REDACTED]</td></tr><tr><th ID="vital4">Heart Rate</th><td>78 /min</td><td>[REDACTED]</td></tr><tr><th ID="vital5">Respiratory Rate</th><td>16 /min</td><td>[REDACTED]</td></tr><tr><th ID="vital6">Height</th><td>63 in</td><td>[REDACTED]</td></tr><tr><th ID="vital7">Weight</th><td>166 lbs</td><td>[REDACTED]</td></tr><tr><th ID="vital8">BMI</th><td>29.4 kg/m2</td><td>[REDACTED]</td></tr><tr><th ID="vital9">Oximetry</th><td>98 %</td><td>[REDACTED]</td></tr><tr><th ID="vital10">Height-cm</th><td>160.02 cm</td><td>[REDACTED]</td></tr><tr><th ID="vital11">Weight-kg</th><td>75.3 kg</td><td>[REDACTED]</td></tr><tr><td colspan="3"><span class="content_span">left foot painleft hip pain</span></td></tr></tbody></table></div><h3><a name="id7" href="#toc">Procedures</a></h3><div><table width="100%" border="1"><thead><tr><th>Procedure</th><th>Date Ordered</th><th>Date Performed</th><th>Result</th><th>Body Site</th></tr></thead><tbody><tr><td ID="procedure1">QuantaFlo</td><td>[REDACTED]</td><td/><td>N/A</td><td/></tr></tbody></table></div><h3><a name="id8" href="#toc">Encounters</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter</th><th>Location</th><th>Date</th><th>Provider</th><th>Diagnosis</th></tr></thead><tbody><tr><td>ClareMedica of Palmetto Bay</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Primary osteoarthritis of both hips M16.0 ; Sciatica, left side M54.32 ; Type 2 diabetes mellitus with other specified complication E11.69 ; Mixed hyperlipidemia E78.2 ; Hypertensive heart disease with heart failure I11.0 ; Chronic diastolic (congestive) heart failure I50.32 ; Long-term (current) use of injectable non-insulin antidiabetic drugs Z79.85 ; Type 2 diabetes mellitus with diabetic polyneuropathy E11.42 ; Long term (current) use of oral hypoglycemic drugs Z79.84 ; Unspecified inflammatory spondylopathy, lumbar region M46.96 ; Spinal enthesopathy, site unspecified M46.00 ; Atherosclerosis of aorta I70.0 ; Memory difficulties R41.3 ; Gastro-esophageal reflux disease without esophagitis K21.9 ; Constipation, unspecified constipation type K59.00 ; History of colon polyps Z86.010 ; Chronic gout without tophus, unspecified cause, unspecified site M1A.9XX0 ; Leg swelling M79.89 ; Osteopenia, unspecified location M85.80 ; Obstructive sleep apnea (adult) (pediatric) G47.33 ; Anxiety disorder, unspecified F41.9 ; Sedative, hypnotic or anxiolytic dependence, uncomplicated F13.20 ; Skin plaque L98.8 and Peripheral arterial disease I73.9</td></tr></tbody></table></div><h3><a name="id9" href="#toc">Assessments</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter Date</th><th>Diagnosis (ICD Code)</th><th>Assessment Notes</th><th>Treatment Notes</th><th>Treatment Clinical Notes</th></tr></thead><tbody><tr><td ID="ref1">[REDACTED]</td><td>Primary osteoarthritis of both hips (ICD-10 - M16.0)</td><td/><td/><td>Intermittent, but not bothersome at this time. Noted on imaging 7/2020 and again 6/2024. Repeat pred taper #45.</td></tr><tr><td ID="ref2">[REDACTED]</td><td>Sciatica, left side (ICD-10 - M54.32)</td><td/><td/><td>Good response to epidural ([REDACTED]), but sx's have since recurred. Previously, had good response to pred taper #45. Repeat taper. F/u w/ neurosurg</td></tr><tr><td ID="ref3">[REDACTED]</td><td>Type 2 diabetes mellitus with other specified complication (ICD-10 - E11.69)</td><td/><td/><td>A1C 6.9 (7/2024).Goal A1C 7.5. Cont metformin ER 500 mg BID. Cont Mounjaro 7.5 mg wkly. Cont statin. </td></tr><tr><td ID="ref4">[REDACTED]</td><td>Mixed hyperlipidemia (ICD-10 - E78.2)</td><td/><td/><td>T Chol 188, HDL 46, TG 137, LDL 117 (6/2024). Currently, on simvastatin. </td></tr><tr><td ID="ref5">[REDACTED]</td><td>Hypertensive heart disease with heart failure (ICD-10 - I11.0)</td><td/><td/><td>BP controlled. Cont same doses of losartan BID and atenolol. </td></tr><tr><td ID="ref6">[REDACTED]</td><td>Chronic diastolic (congestive) heart failure (ICD-10 - I50.32)</td><td/><td/><td>Stable. Noted on [REDACTED] 10/2022. Lungs clear. Cont BB and ARB. Check echo </td></tr><tr><td ID="ref7">[REDACTED]</td><td>Long-term (current) use of injectable non-insulin antidiabetic drugs (ICD-10 - Z79.85)</td><td/><td/><td>A1C 6.9 (7/2024). Cont Mounjaro. </td></tr><tr><td ID="ref8">[REDACTED]</td><td>Type 2 diabetes mellitus with diabetic polyneuropathy (ICD-10 - E11.42)</td><td/><td/><td>A1C 6.9 (7/2024).Goal A1C 7.5. Cont metformin ER 500 mg BID.Cont Mounjaro 7.5 mg wkly. Cont pregabalin. </td></tr><tr><td ID="ref9">[REDACTED]</td><td>Long term (current) use of oral hypoglycemic drugs (ICD-10 - Z79.84)</td><td/><td/><td>A1C 6.9 (7/2024). Cont metformin  </td></tr><tr><td ID="ref10">[REDACTED]</td><td>Unspecified inflammatory spondylopathy, lumbar region (ICD-10 - M46.96)</td><td/><td/><td>Noted on lumbar MRI 2020.  Her chronic low back pain complicated by left sciatica. Good response to epidural given by [REDACTED].</td></tr><tr><td ID="ref11">[REDACTED]</td><td>Spinal enthesopathy, site unspecified (ICD-10 - M46.00)</td><td>Under care Neurology specialist at UM, pending completionof PT recommendedd by specialist</td><td/><td>Has chronic low back pain. Lumbar MRI 2020. Celecoxib prn. </td></tr><tr><td ID="ref12">[REDACTED]</td><td>Atherosclerosis of aorta (ICD-10 - I70.0)</td><td/><td/><td>Stable. States she had abd u/s done at [REDACTED]. Will request report.  </td></tr><tr><td ID="ref13">[REDACTED]</td><td>Memory difficulties (ICD-10 - R41.3)</td><td/><td/><td>Reports worsening memory for the past year. B12, TSH, RPR nl (4/2024). Monitor.  </td></tr><tr><td ID="ref14">[REDACTED]</td><td>Gastro-esophageal reflux disease without esophagitis (ICD-10 - K21.9)</td><td/><td/><td>Responds to famotidine. Cont same prn.  </td></tr><tr><td ID="ref15">[REDACTED]</td><td>Constipation, unspecified constipation type (ICD-10 - K59.00)</td><td/><td/><td>Responds to lactulose. Cont same prn.   </td></tr><tr><td ID="ref16">[REDACTED]</td><td>History of colon polyps (ICD-10 - Z86.010)</td><td/><td/><td>Had colonoscopy in [REDACTED]. Repeat in [REDACTED] </td></tr><tr><td ID="ref17">[REDACTED]</td><td>Chronic gout without tophus, unspecified cause, unspecified site (ICD-10 - M1A.9XX0)</td><td/><td/><td>Asx. Cont allopurinol. Uric acid nl, 6.6 (6/2024). Cont same.  </td></tr><tr><td ID="ref18">[REDACTED]</td><td>Leg swelling (ICD-10 - M79.89)</td><td/><td/><td>Has swelling of ankles and distal LE's. From venous insuff. Cont compression stockings. </td></tr><tr><td ID="ref19">[REDACTED]</td><td>Osteopenia, unspecified location (ICD-10 - M85.80)</td><td/><td/><td>Stable. Last had Dexa in [REDACTED]. Has not yet started supplemental Ca/D, but plans to do so</td></tr><tr><td ID="ref20">[REDACTED]</td><td>Obstructive sleep apnea (adult) (pediatric) (ICD-10 - G47.33)</td><td/><td/><td>Diagnosed by ENT in the past, but did not have recall having PSG. (+)snoring, but no reported apneic spells. Feels poorly rested in AM. Has daytime somnolence. Referred to pulmo for PSG at previous visit.</td></tr><tr><td ID="ref21">[REDACTED]</td><td>Anxiety disorder, unspecified (ICD-10 - F41.9)</td><td/><td/><td>Stable. Responds to lorazepam.    </td></tr><tr><td ID="ref22">[REDACTED]</td><td>Sedative, hypnotic or anxiolytic dependence, uncomplicated (ICD-10 - F13.20)</td><td/><td/><td>Takes lorazepam prn. Cont same as previous.   </td></tr><tr><td ID="ref23">[REDACTED]</td><td>Skin plaque (ICD-10 - L98.8)</td><td/><td/><td>Poss from psoriasis. Has plaques on feet b/l that have decreased in size and thickness of "plaqueness" after taking pred taper. Can apply tacrolimus recommended by podiatrist </td></tr><tr><td ID="ref24">[REDACTED]</td><td>Peripheral arterial disease (ICD-10 - I73.9)</td><td/><td/><td>Stable. Quantaflo: R 0.85, L 1.29. Cont statin.</td></tr><tr><td ID="ref25">[REDACTED]</td><td>Other</td><td/><td/><td>CMP, A1C, lipid panel, TSH</td></tr></tbody></table></div><h3><a name="id10" href="#toc">Plan Of Treatment</a></h3><div><span class="content_span">Medication</span><table width="100%" border="1"><thead><tr><th>Medication Name</th><th>Sig</th><th>Start Date</th><th>Stop Date</th><th>Notes</th></tr></thead><tbody><tr><td ID="potMeds1">predniSONE 5 MG</td><td>4 tabs orally 2 times a day for 4 days, then 3 tabs orally 2 times a day for 1 day, then 2 tabs orally 2 times a day for 1 day, then 1 tab orally 2 times a day for 1 day, then 1 tab Orally Once a day</td><td>[REDACTED]</td><td/><td/></tr></tbody></table><span class="content_span">Pending Test</span><table width="100%" border="1"><thead><tr><th>Test Name</th><th>Order Date</th></tr></thead><tbody><tr><td ID="pendingTest1">QuantaFlo</td><td>[REDACTED]</td></tr></tbody></table><span class="content_span">Referrals</span><table width="100%" border="1"><thead><tr><th>Referral Date</th><th>Details</th></tr></thead><tbody><tr><td ID="referral1">[REDACTED]</td><td>[REDACTED], 2 x per week for 6 wks | Eval and treat,  Select Physical Therapy</td></tr><tr><td ID="referral2">[REDACTED]</td><td>[REDACTED], OSA; eval via polysomnogram,  Blackstone Medical Services</td></tr></tbody></table><span class="content_span">Next Appt</span><table width="100%" border="1"><thead><tr><th>Details</th></tr></thead><tbody><tr><td ID="nextAppt">Follow Up: 4 Weeks, Reason: labs 1 wk before next visit</td></tr><tr><td ID="futureAppt1">Provider Name:[REDACTED], [REDACTED] 09:00:00 AM, [REDACTED][REDACTED], [REDACTED]</td></tr><tr><td ID="futureAppt2">Provider Name:[REDACTED], [REDACTED] 08:40:00 AM, [REDACTED][REDACTED][REDACTED], [REDACTED]</td></tr></tbody></table></div><h3><a name="id11" href="#toc">Progress Notes</a></h3><div><ul><li><table width="99%" border="0" cellspacing="0" cellpadding="0"><thead><tr><td><content>[REDACTED] <span class="bold">DOB:</span> [REDACTED] ([REDACTED] F) <span class="bold">Acc No.</span> 42111 <span class="bold">DOS:</span> [REDACTED]</content></td></tr></thead><tbody><tr><td><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td align="right" colspan="2"><span class="bold">Progress Notes</span></td></tr><tr><td align="left"><span class="bold">Patient: </span>[REDACTED]<br/><span class="bold">Account Number: </span>42111</td><td align="right"><span class="bold">Provider: </span>[REDACTED], MD</td></tr><tr><td align="left"/></tr><tr><td align="left"><span class="bold">DOB: </span>[REDACTED]<span class="bold">   Age: </span>67 Y<span class="bold">   Sex: </span>Female</td><td align="right"><span class="bold">Date: </span>[REDACTED]</td></tr><tr><td><span class="bold">Phone: </span>[REDACTED]</td></tr><tr><td colspan="2"><span class="bold">Address: </span>[REDACTED][REDACTED]</td></tr><tr><td colspan="2"><span class="bold">Structured Data: </span> MRA Deep Review Date : [REDACTED]; MRA- QR Review Date : [REDACTED]</td></tr></tbody></table></li></ul><br/><content><span class="bold">Subjective:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Chief Complaints:</span></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td>   1. Follow up visit. </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">HPI: </span><br/>   <span class="Underline">Consent</span>: <br/>       [REDACTED] female presents for f/u sciatica and DM. Had good response from epidural but that was "2 1/[REDACTED]". Sciatic sx's have since returned.</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Medical History:</span> </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Medications:</span> Taking Celecoxib 100 MG Capsule 1 CAPSULE WITH FOOD ORALLY 2 TIMES A DAY START AFTER COMPLETING PREDNISONE. 30 DAYS   , Taking Pantoprazole Sodium 40 MG Tablet Delayed Release TAKE 1 TABLET BY MOUTH EVERY DAY FOR 30 DAYS   , Taking Proctosol HC 2.5 % Cream 1 application Externally Twice a day As needed to affected area, Taking Allopurinol 100 MG Tablet 1 tablet Orally Once a day , Taking Atenolol 50 MG Tablet 1 tablet Oral Once a day , Taking Clotrimazole-Betamethasone 1-0.05 % Cream  External every 12 hours , Taking dilTIAZem HCl 120 MG Tablet TAKE 1 TABLET BY MOUTH TWICE A DAY FOR 90 DAYS   , Taking Lactulose 10 GM/15ML Solution TAKE 2 TABLESPOONS (30ML) BY MOUTH DAILY BEFORE BED AS NEEDED   , Taking LORazepam 0.5 MG Tablet 1 tablet at bedtime as needed Oral once a day , Taking Losartan Potassium 25 MG Tablet 1 tablet Oral Twice a Day , Taking metFORMIN HCl ER 500 MG Tablet Extended Release 24 Hour 1 tablet with evening meal Orally twice a day , Taking Mounjaro 7.5 MG/0.5ML Solution Pen-injector 7.5 mg Subcutaneous Once a Week Disp: 1 month supply, stop date [REDACTED], Taking oxyBUTYnin Chloride ER 10 MG Tablet Extended Release 24 Hour TAKE 1 TABLET BY MOUTH EVERY DAY Orally Once a day , Taking Simvastatin 10 MG Tablet 1 tablet in the evening Oral Once a day , Taking Pregabalin 100 MG Capsule 1 capsule Orally 3 times a day , stop date [REDACTED], Not-Taking Famotidine 40 MG Tablet 1 tablet at bedtime Orally Once a day , Not-Taking Fluocinonide 0.05 % Cream 1 application Externally Twice a day to affected area, Not-Taking Furosemide 20 MG Tablet TAKE 1 TABLET BY MOUTH EVERY DAY FOR 30 DAYS   , Not-Taking glipiZIDE 5 MG Tablet 1 tablet orally before meals Orally 2 times a day As needed, Not-Taking Ipratropium Bromide 3.0E-4 Solution  Nasal every 12 hours , Unknown Accu-Chek Guide - Strip as directed In Vitro 2 times a day In Vitro twice As needed, Unknown Accu-Chek Guide w/Device Kit as directed   , Unknown Accu-Chek Softclix Lancets - Miscellaneous as directed 2 times a day   , Medication List reviewed and reconciled with the patient</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Allergies:</span> Tylenol: Allergy, Sulfacetamide: Allergy. </td></tr></tbody></table></li></ul><br/><content><span class="bold">Objective:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Vitals:</span> Temp: <span class="bold">97</span> F, HR: <span class="bold">78</span> /min, BP: <span class="bold">125/77</span> mm Hg, Ht: 63 in, Wt: <span class="bold">166</span> lbs, BMI: <span class="bold">29.4</span> Index, Pain scale: <span class="bold">5</span> 1-10, Oxygen sat %: <span class="bold">98</span> %, RR: <span class="bold">16</span> /min, Ht-cm: 160.02 cm, Wt-kg: 75.3 kg, Body Surface Area: 1.83<br/>left foot pain <br/>left hip pain.</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content class="bold">Examination: <br/></content>   <span class="Underline">General Examination:</span><br/>      General appearance: alert, pleasant, no apparent distress,  No acute distress,  Well-groomed. <br/>      Head: normocephalic, atraumatic. <br/>      Heart: regular rate and rhythm without murmurs, gallops, clicks or rubs. <br/>      Lungs: clear to auscultation bilaterally, with good air movement and no rales, rhonchi or wheezes. <br/>      Abdomen: soft with good bowel sounds, nontender, and no masses or hepatosplenomegaly,  no hernias present.    <br/></td></tr><tr><td/></tr></tbody></table></li></ul><br/><content><span class="bold">Assessment:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Assessment: </span></td></tr><tr><td/></tr><tr><td>1. Sciatica, left side - M54.32 (Primary) 2. Primary osteoarthritis of both hips - M16.0 3. Type 2 diabetes mellitus with other specified complication - E11.69 4. Mixed hyperlipidemia - E78.2 5. Hypertensive heart disease with heart failure - I11.0 6. Chronic diastolic (congestive) heart failure - I50.32 7. Long-term (current) use of injectable non-insulin antidiabetic drugs - Z79.85 8. Type 2 diabetes mellitus with diabetic polyneuropathy - E11.42, Src Problem: DM type 2 with diabetic peripheral neuropathy 9. Long term (current) use of oral hypoglycemic drugs - Z79.84 10. Unspecified inflammatory spondylopathy, lumbar region - M46.96 11. Spinal enthesopathy, site unspecified - M46.00, Src Problem: Ligamentum flavum hypertrophy, Under care Neurology specialist at UM, pending completionof PT recommendedd by specialist 12. Atherosclerosis of aorta - I70.0 13. Memory difficulties - R41.3 14. Gastro-esophageal reflux disease without esophagitis - K21.9, Src Problem: GERD (gastroesophageal reflux disease) 15. Constipation, unspecified constipation type - K59.00 16. History of colon polyps - Z86.010 17. Chronic gout without tophus, unspecified cause, unspecified site - M1A.9XX0 18. Leg swelling - M79.89 19. [REDACTED], unspecified location - M85.80 20. Obstructive sleep apnea (adult) (pediatric) - G47.33, Src Problem: OSA (obstructive sleep apnea) 21. Anxiety disorder, unspecified - F41.9 22. Sedative, hypnotic or anxiolytic dependence, uncomplicated - F13.20, Src Problem: Sedative hypnotic or anxiolytic dependence 23. Skin plaque - L98.8 24. Peripheral arterial disease - I73.9 </td></tr></tbody></table></li></ul><br/><content><span class="bold">Plan:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Treatment:</span></td></tr><tr><td><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">1. Sciatica, left side</span> <br/>Start predniSONE Tablet, 5 MG, 4 tabs orally 2 times a day for 4 days, then 3 tabs orally 2 times a day for 1 day, then 2 tabs orally 2 times a day for 1 day, then 1 tab orally 2 times a day for 1 day, then 1 tab, Orally, Once a day, 45, Refills 0.  <br/>Clinical Notes: Good response to epidural ([REDACTED]), but sx's have since recurred. Previously, had good response to pred taper #45. Repeat taper. F/u w/ neurosurg          <br/> Referral To:Physical Therapist<br/>              Reason:2 x per week for 6 wks <br/></td></tr><tr><td/></tr><tr><td><span class="bold">2. Primary osteoarthritis of both hips</span> <br/>Clinical Notes: Intermittent, but not bothersome at this time. Noted on imaging 7/2020 and again 6/2024. Repeat pred taper #45.          <br/> Referral To:Physical Therapist<br/>              Reason:2 x per week for 6 wks <br/></td></tr><tr><td/></tr><tr><td><span class="bold">3. Type 2 diabetes mellitus with other specified complication</span> <br/>Clinical Notes: A1C 6.9 (7/2024).Goal A1C 7.5. Cont metformin ER 500 mg BID. Cont Mounjaro 7.5 mg wkly. Cont statin.   </td></tr><tr><td/></tr><tr><td><span class="bold">4. Mixed hyperlipidemia</span> <br/>Clinical Notes: T Chol 188, HDL 46, TG 137, LDL 117 (6/2024). Currently, on simvastatin.   </td></tr><tr><td/></tr><tr><td><span class="bold">5. Hypertensive heart disease with heart failure</span> <br/>Clinical Notes: BP controlled. Cont same doses of losartan BID and atenolol.   </td></tr><tr><td/></tr><tr><td><span class="bold">6. Chronic diastolic (congestive) heart failure</span> <br/>Clinical Notes: Stable. Noted on [REDACTED] 10/2022. Lungs clear. Cont BB and ARB. Check echo   </td></tr><tr><td/></tr><tr><td><span class="bold">7. Long-term (current) use of injectable non-insulin antidiabetic drugs</span> <br/>Clinical Notes: A1C 6.9 (7/2024). Cont Mounjaro.   </td></tr><tr><td/></tr><tr><td><span class="bold">8. Type 2 diabetes mellitus with diabetic polyneuropathy</span> <br/>Clinical Notes: A1C 6.9 (7/2024).Goal A1C 7.5. Cont metformin ER 500 mg BID.Cont Mounjaro 7.5 mg wkly. Cont pregabalin.   </td></tr><tr><td/></tr><tr><td><span class="bold">9. Long term (current) use of oral hypoglycemic drugs</span> <br/>Clinical Notes: A1C 6.9 (7/2024). Cont metformin    </td></tr><tr><td/></tr><tr><td><span class="bold">10. Unspecified inflammatory spondylopathy, lumbar region</span> <br/>Clinical Notes: Noted on lumbar MRI 2020.  Her chronic low back pain complicated by left sciatica. Good response to epidural given by [REDACTED].  </td></tr><tr><td/></tr><tr><td><span class="bold">11. Spinal enthesopathy, site unspecified</span> <br/>Clinical Notes: Has chronic low back pain. Lumbar MRI 2020. Celecoxib prn.   </td></tr><tr><td/></tr><tr><td><span class="bold">12. Atherosclerosis of aorta</span> <br/>Clinical Notes: Stable. States she had abd u/s done at [REDACTED]. Will request report.    </td></tr><tr><td/></tr><tr><td><span class="bold">13. Memory difficulties</span> <br/>Clinical Notes: Reports worsening memory for the past year. B12, TSH, RPR nl (4/2024). Monitor.    </td></tr><tr><td/></tr><tr><td><span class="bold">14. Gastro-esophageal reflux disease without esophagitis</span> <br/>Clinical Notes: Responds to famotidine. Cont same prn.    </td></tr><tr><td/></tr><tr><td><span class="bold">15. Constipation, unspecified constipation type</span> <br/>Clinical Notes: Responds to lactulose. Cont same prn.     </td></tr><tr><td/></tr><tr><td><span class="bold">16. History of colon polyps</span> <br/>Clinical Notes: Had colonoscopy in [REDACTED]. Repeat in [REDACTED]   </td></tr><tr><td/></tr><tr><td><span class="bold">17. Chronic gout without tophus, unspecified cause, unspecified site</span> <br/>Clinical Notes: Asx. Cont allopurinol. Uric acid nl, 6.6 (6/2024). Cont same.    </td></tr><tr><td/></tr><tr><td><span class="bold">18. Leg swelling</span> <br/>Clinical Notes: Has swelling of ankles and distal LE's. From venous insuff. Cont compression stockings.   </td></tr><tr><td/></tr><tr><td><span class="bold">19. Osteopenia, unspecified location</span> <br/>Clinical Notes: Stable. Last had Dexa in [REDACTED]. Has not yet started supplemental Ca/D, but plans to do so  </td></tr><tr><td/></tr><tr><td><span class="bold">20. Obstructive sleep apnea (adult) (pediatric)</span> <br/>Clinical Notes: Diagnosed by ENT in the past, but did not have recall having PSG. (+)snoring, but no reported apneic spells. Feels poorly rested in AM. Has daytime somnolence. Referred to pulmo for PSG at previous visit.          <br/> Referral To:Sleep Medicine<br/>              Reason:OSA; eval via polysomnogram <br/></td></tr><tr><td/></tr><tr><td><span class="bold">21. Anxiety disorder, unspecified</span> <br/>Clinical Notes: Stable. Responds to lorazepam.      </td></tr><tr><td/></tr><tr><td><span class="bold">22. Sedative, hypnotic or anxiolytic dependence, uncomplicated</span> <br/>Clinical Notes: Takes lorazepam prn. Cont same as previous.     </td></tr><tr><td/></tr><tr><td><span class="bold">23. Skin plaque</span> <br/>Clinical Notes: Poss from psoriasis. Has plaques on feet b/l that have decreased in size and thickness of "plaqueness" after taking pred taper. Can apply tacrolimus recommended by podiatrist   </td></tr><tr><td/></tr><tr><td><span class="bold">24. Peripheral arterial disease</span> <br/>     <span class="Underline">Procedure: QuantaFlo</span><br/>Clinical Notes: Stable. Quantaflo: R 0.85, L 1.29. Cont statin.  </td></tr><tr><td/></tr><tr><td><span class="bold">25. Others </span> <br/>Clinical Notes: CMP, A1C, lipid panel, TSH  </td></tr><tr><td/></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Recommended Wellness and Prevention Guidelines: </span></td></tr></tbody></table></li></ul><ul><li><table border="1"><tbody><tr><td colspan=""> Status</td><td colspan=""> Alert</td><td colspan=""> Last Done</td><td colspan=""> Next Due</td><td colspan=""> Action Taken</td></tr><tr><td colspan=""> NONCOMPLIANT</td><td colspan=""> Colorectal Cancer Screening (Colonoscopy)</td><td colspan=""> - </td><td colspan=""> [REDACTED]</td><td colspan=""> -</td></tr><tr><td colspan=""> NONCOMPLIANT</td><td colspan=""> Colorectal Cancer Screening (FOBT Status)</td><td colspan=""> - </td><td colspan=""> [REDACTED]</td><td colspan=""> -</td></tr><tr><td colspan=""> NONCOMPLIANT</td><td colspan=""> QuantaFlo</td><td colspan=""> [REDACTED] (O)</td><td colspan=""> [REDACTED]</td><td colspan=""> Ordered QuantaFlo</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Procedure Codes:</span> 3078F DIAST BP &lt;80 MM HG, 3074F SYST BP LT 130 MM HG, 93922 EXTREMITY STUDY, 1159F MED LIST DOCD IN RCRD, 1160F RVW MEDS BY RX/DR IN RCRD, 1125F AMNT PAIN NOTED PAIN PRSNT, 3044F HG A1C LEVEL LT 7.0%, 3049F LDL-C 100-129 MG/DL, 93922 EXTREMITY STUDY, 1118F GERD SYMPS ASSESSED 12 MONTH</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Follow Up:</span> 4 Weeks (Reason: labs 1 wk before next visit)</td></tr></tbody></table></li></ul><ul><li/></ul><br/><content><span class="bold">Billing  Information:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content><span class="bold">Visit Code:</span></content> <br/>99214 Office Visit, Est Pt., Level 4.  Modifiers: 25</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content><span class="bold">Procedure Codes:</span></content> <br/>3078F DIAST BP &lt;80 MM HG. <br/>3074F SYST BP LT 130 MM HG. <br/>93922 EXTREMITY STUDY. <br/>1159F MED LIST DOCD IN RCRD. <br/>1160F RVW MEDS BY RX/DR IN RCRD. <br/>1125F AMNT PAIN NOTED PAIN PRSNT. <br/>3044F HG A1C LEVEL LT 7.0%. <br/>3049F LDL-C 100-129 MG/DL. <br/>93922 EXTREMITY STUDY. <br/>1118F [REDACTED] ASSESSED 12 MONTH. </td></tr></tbody></table></li></ul><br/><ul><li><table width="100%" border="0"><tbody><tr><td/></tr><tr><td valign="top">Electronically signed by [REDACTED] , MD  on [REDACTED] 11:11 AM EDT</td></tr><tr><td valign="top">Sign off status: Completed</td></tr><tr><td/></tr></tbody></table></li></ul><span class="content_span">true</span></td></tr></tbody><tbody><tr><td><br/><ul><li><table width="100%" border="0" cellpadding="0" cellspacing="0"><tbody><tr><td align="left"><span class="bold">Provider:</span> [REDACTED], MD</td><td align="right"><span class="bold">Date: </span>[REDACTED]</td></tr><tr><td/><td align="right"><span class="content_span">Generated for Printing/Faxing/eTransmitting on: [REDACTED] 12:23 PM EDT</span></td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></div><h3><a name="id12" href="#toc">History and Physical Notes</a></h3><div><ul><li><p>Examination</p><table width="100%" border="1"><colgroup><col width="20%"/><col width="20%"/><col width="40%"/><col width="20%"/></colgroup><thead><tr><th>Category</th><th>Sub-Category</th><th>Detail</th><th>Notes</th></tr></thead><tbody><tr><td rowspan="5">General Examination</td><td>General appearance:</td><td colspan="2">alert, pleasant, no apparent distress, No acute distress, Well-groomed</td></tr><tr><td>Head:</td><td colspan="2">normocephalic, atraumatic</td></tr><tr><td>Heart:</td><td colspan="2">regular rate and rhythm without murmurs, gallops, clicks or rubs</td></tr><tr><td>Lungs:</td><td colspan="2">clear to auscultation bilaterally, with good air movement and no rales, rhonchi or wheezes</td></tr><tr><td>Abdomen:</td><td colspan="2">soft with good bowel sounds, nontender, and no masses or hepatosplenomegaly, no hernias present</td></tr></tbody></table><br/></li></ul></div><h3><a name="id13" href="#toc">Consultation Request Notes</a></h3><div><table width="100%" border="1"><tbody><tr><th>Referral Date</th><th>Referring Provider</th><th>Referred Provider</th><th>Notes</th></tr><tr ID="ConsultationNote1"><td>[REDACTED]</td><td>[REDACTED]</td><td>Select Physical Therapy, </td><td>2 x per week for 6 wks | Eval and treat</td></tr><tr ID="ConsultationNote2"><td>[REDACTED]</td><td>[REDACTED]</td><td>Blackstone Medical Services, </td><td>OSA; eval via polysomnogram</td></tr></tbody></table></div><br/><br/>
</body></html>